Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab in localized scleroderma
2019-002036-90Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Oct 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial in morphea comparing Dupixent with Placebo (2 arms). Started Oct 2019; status: completed.
02
Drugs
03
Conditions
morphea
Beyond the preview
Go deeper on 2019-002036-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002036-90.